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Homeopathic Treatment of animal diseases is required in organic farming at least since EU 
Regulation 1804/99 according organic animal husbandry is valid for all organic producers. While 
practitioners report good results of homeopathic treatment in clinical bovine mastitis there are few 
studies showing satisfying effects of these remedies. In most of the studies the effects of 
homeopathics were controlled not at all by a reference group (OTTO, 1984) or by antibiotic 
treatment (MERCK et al., 1989; GARBE, 2003). RCT trials with placebo control in prevention and 
subclinical mastitis provided no benefits (MEANEY, 1994, EGAN, 1994; GARBE, 2003). 
Thus, to evaluate net effects of homeopathics in mastitis treatment it was essential to conduct a 
placebo controlled RCT. In an organic herd of about 300 dairy cows the following questions 
should answered:
1.Are homeopathic effects stronger than placebo in clinical dairy cow mastitis?
2. Is a homeopathy supported udder health programme able reduce antibiotics in mastitis 
control?
3. Is such a programme able to maintain or increase udder health?
Furthermore, the results should lead to a catalogue of recommendations for conversion from a 
conventional to a homeopathy supported udder health control programme.
The investigation was conducted in a Brandenburg bio-dyn herd of about 300 cows in two 
phases. After the first part in July 2002 the results preliminarily were evaluated and then the 
whole concept due to unsatisfying results was adapted (s. Tab. 1/2). In Phase 1 a number of 121 
clinical mastitis cases with 137 affected quarters matched the including criteria, in Phase 2 the 
number was 126 cows with 148 quarters. These animals were allocated to a code number which 
classified the case to Verum (n=65 and n=60) or placebo group (n=56 and n=66). 
In Figure 1 and 2 the cure rates in both phases on cow level and quarter level compared to 
placebo are shown. While there is no difference between the cows in phase 1, on quarter level 
the verum group showed a significant higher complete cure rate than placebo group. 
These results are balanced by additional antibiotics treatment in case of therapy failure in the 
placebo group. The complete cure rate in the verum group after 8 weeks is 32% compared to 
13% in placebo group (p<0.05). 
The limited cure results in single cows did not lead to an udder health depression of the herd 
(Fig. 3). During the study the mean of somatic cell count could decreased by 100.000 cells/ml 
while the milk yield increased slightly by 250 kg/cow to 6.500 kg/cow/year.   
The cure rates during the investigation were not satisfying independent of the therapy 
protocol. But the increasing cure rates in the second part of the study are influenced by the 
enhancement of environmental preconditions in combination with the simplified therapy 
scheme. The therapists seemed to be more familiar with the fixed combinations of 
homeopathics so that positive effects of the homeopathics in case of bacterial caused mastitis 
compared to placebo can be seen in this phase. 
After additional antibiotic treatments in case of therapy failure in specific infections (i.e. 
streptococci and staph. aureus) the cure rates could be elevated to a satisfying level. This fact 
shows that the limited and controlled use of antibiotics in organic herds can be helpful in the 
mastitis control. Similar experiences are made in the investigation of GARBE (2003).
Regardless the conceptual modification to an antibiotic emergency concept, the massive 
reduction of antibiotics in combination with an increase of herd udder health justifies the 
therapy protocol in the second phase of the study. 
The answer of the amount of net effects of the homeopathic remedies could not given. 
Hypothetically, the self cure of the animals is higher than known. On the other hand it seems 
to be discussable if a not treated or attended mastitis cow is able to develop self cure. The 
care of the animal by the farmer and the therapist and the interaction between them and the 
cow could be a crucial criterion for the positive development of disease. Regardless of this 
point, animal welfare aspects forbid the omission of treatment.
As a conclusion, the integrated system consisting of preventive herd measures and 
complementary therapy added by limited antibiotic therapy can be recommended for other 
herds which are willing to modify conventional udder health concepts to a complementary 
programme. The precondition for the success is the attendance to optimize environmental 
conditions regardless economic aspects. The therapy system should be transparent, simple 
and easy to use. The farmer and involved veterinarian should not engaged to invest a lot of 
additional work. However, it is necessary to reflect every single mastitis case as a special 
one. So a limited but certain investment of work is required.
Regarding these preconditions a massive antibiotics reduction in combination with a stable 
udder health is possible. 
Fig. 1: Clinical Cure Rates (CCR) of COWs 5 and 8 weeks after
therapy termination comparing Verum (n=65 and 60 in Phase 1 
and 2) and placebo group (n= 56 and 66 in Phase 1 and 2)
In case of clinical mastitis cows were isolated, clinically investigated and afterwards treated by 
the oral dilution contending the required homeopathics. Every case had ist own coded package of 
possible remedies. Animals were treated twice a day for 5 to 14 days (Phase 2: 1 to 7 days) 
depending on development of disease. In case of therapy failure in Phase 1 all animals were 
treated by an not coded homeopathic preparation and in Phase 2 by antibiotics according to 
bacteriological findings.
Milk samples (double samples) for bacteriological and cell count investigation were taken before 
treatment (M1), 4 to 5 weeks after treatment termination (M2) and 7 to 8 weeks after treatment 
termination (M3). To evaluate the herd situation additional samples were taken after calving and 
before dry off.
Healing criteria on the cow level was the clinical cure without secondary therapy and release to 
production. On quarter level the cure was determined by bacterial findings (BCR) and additional 
by cytological findings. A quarter was determined as „completely cured“, if no bacteria were found 
AND the cell count was below 100.000/ml.
To assess the reduction of antibiotics within the concept we assumed that the mastitis cows 
yielded 20,5 kg milk per day, was treated under conventional conditions by antibiotics over 3 days 
with a mean withdrawal time of 5 days (doubled in organic herds) and compared these theoretical 
values with the extrapolated antibiotics input within our concept.  
Characteristics Phase 1 (Aug 2001 - Jul 2002)
• No antibiotic treatment allowed
• No antibiotic dry off therapy allowed 
• decreased environmental herd situation
• Therapy Protocol
• acute Mastitis: Phytolacca D6, Echinacea D6 
+ selective remedies: Bryonia D6 or Aconitum D6 
or Belladonna D6 depending on clinical findings as 
oral mixture preparation
• chronical Mastitis: Echinacea D6, Phytolacca
D6 and Hepar Sulfuris D8 as oral mixture 
preparation
Tab.1/2: Feautures of the investigations in the two phases
Discussion and Conclusion
Results
Material and Methods
Introduction
P3174
One of the main objectives of the study was to reduce antibiotics in mastitis control of organic 
herds. The number of actual antibiotic treatments during observation time compared to the 
number of mastitis cases showed a reduction by 75%. Figure 4 shows the extrapolated 
reduction of milk loss by withdrawal (-25.000kg) and the reduction of contaminated milk 
during treatment time (-13.100 kg).
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Characteristics Phase 2 (Jan 2003 – Dec 2003) 
• Antibiotic treatment allowed in case of therapy failure
• Antibiotic dry off therapy in specific infections
• a lot of herd enhancement measures
• Therapy Protocol
• acute Mastitis: Phytolacca D6, Echinacea D6, 
Bryonia D6 and Belladonna D6 as oral mixture 
preparation (+Aconitum D6 with fever >40°C)
• chronical Mastitis: Echinacea D6, Phytolacca
D6 and Hepar Sulfuris D8 as oral mixture 
preparation 
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Fig. 2: Bacteriological and Complete Cure Rates (CCR) of  
QUARTERSs affected by pathogenic bacteria 5 and 8 weeks after
therapy termination comparing Verum (n=53) and placebo group
(n= 54) in Phase 2 of the investigation
Fig. 3: Essential herd milk parameters „MILK YIELD“ and 
„SOMATIC CELL COUNT“ during the time of investigation
Fig. 4:Projection of Milk loss by Therapy
Concept; hypothetical values considering mean
Daily milk yield 20,5 kg/cow/day; withdrawel time
5 days x 2 (organic regulations); therapy time 3 days